KL and cardiac hypertrophy: According to the above-mentioned experimental studies, FGF23 and/or α-Klotho may induce or reduce cardiac hypertrophy; however, clinical data demonstrating an association between circulating levels of FGF23 and/or α-Klotho and cardiac abnormalities among subjects without renal dysfunction remain limited.